Submission Archives - MaaT Pharma

Press Releases

June 2, 2025: MaaT Pharma Advances Toward Commercialization And Submits Marketing Authorization Application to the European Medicines Agency (EMA) for Xervyteg® (MaaT013) in Acute Graft-versus-Host Disease

MaaT Pharma Advances Toward Commercialization And Submits Marketing Authorization Application to the European Medicines Agency…

MaaT PharmaJune 2, 2025

© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club